<unk>  is used in combination with the progestin DHPA as a once-monthly combined injectable contraceptive for women in Latin America and Hong Kong.<unk>  has been studied in feminizing hormone therapy for transgender women as well. The combination of<unk>  and DHPA has likewise been used by transgender women for such purposes. Available forms The following forms of<unk>  are or have been available for use: *<unk>  10 mg and DHPA 150 mg (brand names Perlutal, Topasel, many others) *<unk>  5 mg and DHPA 75 mg (brand names Anafertin, Patector NF, Yectames) *<unk>  10 mg and DHPA 120 mg (brand names Unalmes, Yectuna) *<unk>  10 mg and DHPA 75 mg (brand name Ova Repos; discontinued) A 6 mg<unk>  and 90 mg DHPA formulation was also studied, but was never marketed. The combination of<unk>  and DHPA has also been studied at other doses ranging from 5 to 50 mg<unk>  and 75 to 200 mg DHPA. The combination of<unk>  and DHPA is provided in ampoules at<unk>  concentrations of 5 mg/mL and 10 mg/mL.
Estradiol enantate
Estradiol undecylate
Estradiol dienantate
Estradiol furoate
Estradiol valerate
Hexestrol diphosphate
Estradiol dipropionate
Estradiol cypionate